Pro- and antiinflammatory cytokine production after radiofrequency ablation of unresectable hepatic tumors

被引:44
|
作者
Schell, SR
Wessels, FJ
Abouhamze, A
Moldawer, LL
Copeland, EM
机构
[1] Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA
[3] Malcolm Randall Vet Affairs Med Ctr, Surg Serv, Gainesville, FL USA
关键词
D O I
10.1016/S1072-7515(02)01333-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Experience using radiofrequency ablation (REA) for treating unresectable hepatic malignancies is expanding, with promising outcomes and fewer complications compared with cryotherapy. This study examined systemic inflammatory responses after REA as measured by the appearance of postoperative symptoms and cytokine production. STUDY DESIGN: Seventeen patients (11 men, 6 women) aged 40 to 85 years (mean 64.2 years) with unresectable primary and metastatic hepatic tumors underwent REA. Mean liver volume treated with REA was 35.3% +/- 3.6% (SEM) (median 36.8%). Plasma cytokines (tumor necrosis factor-alpha, interleukin [IL]-1beta, IL-Ira, IL-6, IL-8, IL-10, p55, and p75) were measured from anesthesia induction through 48 hours after RFA. Ex vivo whole-blood cytokine production was measured at baseline, 24 hours, and 48 hours after REA. RESULTS: Cytokine and cytokine-receptor production were not notably altered by REA. Ex vivo whole-blood endotoxin stimulation indicated that intrinsic cellular immune function remained intact after treatment, although modest decreases in Stimulated tumor necrosis factor a production were observed 24 to 48 hours after REA. Variceal bleeding, hepatic failure, and death occurred in one patient 30 days after RFA. None of the remaining patients exhibited tachycardia or hypotension. Fevers (greater than or equal to38.5degreesC) developed in three patients during the First 48 hours postoperatively. There was no association between plasma cytokines and postoperative complications. CONCLUSIONS: In contrast to previous reports using cryotherapy, systemic inflammatory responses as measured by increased cytokines were not observed after REA. The cryotherapy-induced "cryoshock" phenomenon was not observed in patients undergoing RFA in our study. We conclude that REA ablation is fundamentally different than cryotherapy and apparently does not stimulate Kupffer and other hepatic macrophages to produce proinflammatory cytokines.
引用
收藏
页码:774 / 781
页数:8
相关论文
共 50 条
  • [21] Adverse events after radiofrequency ablation of unresectable liver tumors: a single-center experience
    Lao, Oliver B.
    Farjah, Farhood
    Flum, David R.
    Yeung, Raymond S.
    AMERICAN JOURNAL OF SURGERY, 2009, 198 (01): : 76 - 82
  • [22] Long-term survival after radiofrequency ablation of complex unresectable liver tumors - Discussion
    Biehl, T
    Bilchik
    Haun, WE
    Sticca, RP
    ARCHIVES OF SURGERY, 2006, 141 (06) : 587 - 588
  • [23] Role of endogenous ATP in the regulation of pro- and anti antiinflammatory mediator production
    Vizi, ES
    Haskó, G
    Lendvai, B
    Sperlágh, B
    DRUG DEVELOPMENT RESEARCH, 2001, 53 (2-3) : 117 - 125
  • [24] Pro- and antiinflammatory cytokine signaling: Reciprocal antagonism regulates interferon-gamma production by human natural killer cells
    Yu, Jianhua
    Wei, Min
    Becknell, Brian
    Trotta, Rossana
    Liu, Shujun
    Boyd, Zachary
    Jaung, Michael S.
    Blaser, Bradley W.
    Sun, Jin
    Benson, Don M., Jr.
    Mao, Hsiaoyin
    Yokohama, Akihiko
    Bhatt, Darshna
    Shen, Lei
    Davuluri, Ramana
    Weinstein, Michael
    Marcucci, Guido
    Caligiuri, Michael A.
    IMMUNITY, 2006, 24 (05) : 575 - 590
  • [25] Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms -: A proposed algorithm -: Discussion
    Eckhauser, FE
    Stain, S
    Schneider, PD
    O'Connell, TX
    Latimer, RG
    Chapman, WC
    Abcarian, H
    Morris, DM
    Smith, J
    Donovan, A
    Bilchik
    ARCHIVES OF SURGERY, 2000, 135 (06) : 662 - 664
  • [26] Laparoscopic radiofrequency ablation of unresectable hepatic malignancies - A phase 2 trial
    Chung, MH
    Wood, TF
    Tsioulias, GJ
    Rose, DM
    Bilchik, AJ
    SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES, 2001, 15 (09): : 1020 - 1026
  • [27] Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence
    Ayav, Ahmet
    Germain, Adeline
    Marchal, Frederic
    Tierris, Ioannis
    Laurent, Valerie
    Bazin, Christophe
    Yuan, Yufeng
    Robert, Laurence
    Brunaud, Laurent
    Bresler, Laurent
    AMERICAN JOURNAL OF SURGERY, 2010, 200 (04): : 435 - 439
  • [28] Laparoscopic radiofrequency ablation of unresectable hepatic malignanciesA phase 2 trial
    M. H. Chung
    T. F. Wood
    G. J. Tsioulias
    D. M. Rose
    A. J. Bilchik
    Surgical Endoscopy, 2001, 15 (9) : 1020 - 1026
  • [29] Laparoscopic radiofrequency ablation of unresectable hepatic malignancies: Indication, limitation and results
    Hildebrand, Philipp
    Kleemann, Markus
    Roblick, Uwe
    Mirow, Lutz
    Birth, Matthias
    Bruch, Hans-Peter
    HEPATO-GASTROENTEROLOGY, 2007, 54 (79) : 2069 - 2072
  • [30] Percutaneous radiofrequency ablation of hepatic tumors: Postablation syndrome
    Dodd, GD
    Napier, D
    Schoolfield, JD
    Hubbard, L
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 185 (01) : 51 - 57